Financial News · Live Terminal

Page 222 of 308

William Blair Downgrades Tenable to Market Perform From Outperform

Tenable (TENB) has an average rating of overweight and mean price target of $29.26, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$TENB

Research60d ago

Leerink Upgrades NeoGenomics to Outperform From Market Perform, Adjusts Price Target to $25 From $12

NeoGenomics (NEO) has an average rating of overweight and mean price target of $14.61, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NEO

Research60d ago

Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53

QIAGEN (QGEN) has an average rating of overweight and mean price target of $47.69, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$QGEN

Research60d ago

Arete Research Upgrades Nokia to Buy From Neutral

Nokia (NOK) has an average rating of overweight and mean price target of $10.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NOK

Research60d ago

Loop Capital Initiates Legence Corp at Buy

Legence Corp. Class A (LGN) has an average rating of buy and mean price target of $75.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LGN

Research60d ago

Guggenheim Initiates Corbus Pharmaceuticals at Buy With $45 Price Target

Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CRBP

Research60d ago

Evercore ISI Initiates Standard Lithium at Outperform

$SLI

Research60d ago

Loop Capital Upgrades MaxLinear to Buy From Hold, Adjusts Price Target to $75 From $17

MaxLinear (MXL) has an average rating of overweight and mean price target of $49.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MXL

Research60d ago

Stifel Upgrades Crane to Buy From Hold, Adjusts Price Target to $215 From $200

Crane (CR) has an average rating of overweight and mean price target of $224, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CR

Research60d ago

BNP Paribas Initiates Alibaba Group at Outperform With $209 Price Target

Alibaba Group Holding (BABA) has an average rating of buy and mean price target of $188.65, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BABA

Research60d ago

BofA Securities Upgrades Radian Group to Buy From Underperform

Radian Group (RDN) has an average rating of overweight and mean price target of $41.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$RDN

Research60d ago

William Blair Initiates Aktis Oncology at Outperform

Aktis Oncology, Inc. (AKTS) has an average rating of buy and mean price target of $32.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$AKTS

Research60d ago

BofA Securities Upgrades Elevance Health to Buy From Neutral, $435 Price Target

Elevance Health (ELV) has an average rating of overweight and mean price target of $384.05, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ELV

Research60d ago

Raymond James Downgrades Universal Health Services to Market Perform From Outperform

Universal Health Services (UHS) has an average rating of overweight and mean price target of $231.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$UHS

Research60d ago

Research Alert: Arx: Record Q1 Production As Shell Announces Cad22 Billion Acquisition

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ARC Resources (ARX) delivered record Q1 production of 418,522 boe/day, up 12% Y/Y, with funds from operations of CAD967M (CAD1.70/share, +17% per share) and free funds flow of CAD459M (CAD0.81/share, +19% per share Y/Y). Strong natural gas pricing of CAD4.51/Mcf and higher volumes led to the outperformance, while the company returned CAD256M to shareholders (56% of free funds flow) through dividends and share repurchases. On April 27, ARX announced a CAD22B acquisition by Shell at CAD32.80/share, representing a 27% premium and validating the company's operational excellence. Management maintained 2026 guidance of 405,000-420,000 boe/day production and CAD1.8B-CAD1.9B in capital spending, though Q2 will see planned turnaround impacts. The quarter demonstrates why Shell pursued this strategic acquisition, as ARX achieved double-digit production growth and strong gas pricing realization. We expect shares to trade near the CAD32.80 offer price barring any closing complexities.

$ARX

Research60d ago

KeyBanc Upgrades Zeta Global Holdings to Overweight From Sector Weight, Sets $22 Price Target

Zeta Global Holdings (ZETA) has an average rating of buy and mean price target of $28.38 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ZETA

Research60d ago

Research Alert: Yum China Q1 In Line; Aggressive Expansion, Digital Growth Support Outlook

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:YUMC reported Q1 2026 revenue growth of 10% to $3.27B, in line with consensus of $3.23B, with system sales up 4% and steady same-store sales. The quarter featured record store expansion with 636 net openings (39% by franchisees), bringing the total count to 18,737 and supporting the 20,000+ store target by year-end 2026. We view the franchise acceleration as supporting capital efficiency, though benefits may be limited in lower-tier cities due to varying price points and higher customer acquisition costs, in our opinion. Management remains confident in achieving 2026 targets, citing improved delivery platform dynamics and a dual focus on innovation and efficiency. Core operating margin expanded 20 bps to 13.6% for the eighth consecutive quarter, with Pizza Hut gaining 110 bps while KFC fell 20 bps due to its margin-dilutive delivery mix. Digital membership grew 9% to 270M, underpinning customer capabilities. Starting in 2027, YUMC plans to return 100% of annual FCF, translating to $900M-$1B+ annually.

$YUMC

Research61d ago

Deutsche Bank Downgrades Sysco to Hold From Buy, Adjusts Price Target to $84 From $90

Sysco (SYY) has an average rating of overweight and mean price target of $86.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SYY

Research61d ago

Daiwa Securities Downgrades Boston Scientific to Neutral From Outperform, Adjusts PT to $60 From $83

Boston Scientific (BSX) has an average rating of buy and mean price target of $85.84, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BSX

Research61d ago

JPMorgan Downgrades Brown-Forman to Underweight From Neutral, Adjusts PT to $23 From $27

Brown-Forman (BF.B) has an average rating of hold and mean price target of $28.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BF.B

Showing 4421-4440 of 6146